Health & Medicine World stem cells & regenerative medicine congress, london, may 22, 2013

1. This presentation is intended to present a summary of ACT’s (“ACT”, or “Advanced Cell Technology Inc”, or “the Company”) salient business characteristics.…

Health & Medicine Act april13regen-med-investor-day

1. This presentation is intended to present a summary of ACT’s (“ACT”, or “Advanced Cell Technology Inc”, or “the Company”) salient business characteristics.…

Health & Medicine Act corporate-bioeuropemarch13

LEADING REGENERATIVE MEDICINE This presentation is intended to present a summary of ACT’s (“ACT”, or “Advanced Cell Technology Inc”, or “the Company”) salient…